Although CD26 has been identified as a leukemic stem cell marker in CML, its simultaneous expression in healthy stem cells probably excludes it as a possible target, at least for current constructs [98, 99]. Here, DPP4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.